Literature DB >> 3540245

Somatic gene therapy for human disease: background and prospects. Part I.

F D Ledley.   

Abstract

Entities:  

Mesh：

Year:  1987        PMID： 3540245     DOI： 10.1016/s0022-3476(87)80278-0

Source DB:  PubMed          Journal:  J Pediatr        ISSN： 0022-3476            Impact factor:   4.406


× No keyword cloud information.
  7 in total

Review 1.  Bronchopulmonary dysplasia: then and now.

Authors:  W H Northway
Journal:  Arch Dis Child       Date:  1990-10       Impact factor: 3.791

2.  Clinical application of somatic gene therapy in inborn errors of metabolism.

Authors:  F D Ledley
Journal:  J Inherit Metab Dis       Date:  1990       Impact factor: 4.982

Review 3.  Recent advances in somatic gene therapy for hereditary respiratory diseases.

Authors:  C A Owen
Journal:  Thorax       Date:  1992-04       Impact factor: 9.139

4.  Retroviral gene transfer into primary hepatocytes: implications for genetic therapy of liver-specific functions.

Authors:  F D Ledley; G J Darlington; T Hahn; S L Woo
Journal:  Proc Natl Acad Sci U S A       Date:  1987-08       Impact factor: 11.205

5.  Structure and expression of human dihydropteridine reductase.

Authors:  J Lockyer; R G Cook; S Milstien; S Kaufman; S L Woo; F D Ledley
Journal:  Proc Natl Acad Sci U S A       Date:  1987-05       Impact factor: 11.205

6.  A research for the relationship between human papillomavirus and human uterine cervical carcinoma. II. Molecular genetic and ultrastructural study on the transforming activity of recombinant retrovirus containing human papillomavirus type 16 subgenomic sequences.

Authors:  J Y Si; K Lee; W Zhang; R C Han; G X Song; L F Chen; W M Zhao; L P Jia; S Liu; Y Y Mai
Journal:  J Cancer Res Clin Oncol       Date:  1991       Impact factor: 4.553

7.  Molecular cloning of L-methylmalonyl-CoA mutase: gene transfer and analysis of mut cell lines.

Authors:  F D Ledley; M Lumetta; P N Nguyen; J F Kolhouse; R H Allen
Journal:  Proc Natl Acad Sci U S A       Date:  1988-05       Impact factor: 11.205
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.